Scapa Group plc is a global supplier of bonding solutions and manufacturer of adhesive-based products for the Healthcare and Industrial markets. Scapa has a global footprint, with production sites in Asia, Europe and the US.
Our worldwide service and supply chain capabilities place us in an excellent position to partner with global customers. We are focused on sustainable growth and innovation, improving the solutions for our customers by applying our knowledge and expertise in advanced material technology and process solutions.
We conduct our activities through two distinct and separate businesses: Healthcare and Industrial, each with its own focus and strategy.
Scapa Healthcare is a leading strategic outsource partner of choice in the Advanced Wound Care, Consumer Wellness, Medical Device Fixation and Drug Delivery markets.
Scapa Industrial operates across a diverse range of market segments throughout Europe, North America and Asia, via the two business models of Engineered Products and Commercial Products.
Find out more »
Modern Slavery Act »
Toxic Reduction Plan 2011 »
Scapa announces the launch of its new Healthcare focused website www.scapahealthcare.com
The new site has extensive content dedicated to the Healthcare market place, including information on our range of Scapa Soft-Pro® skin friendly adhesives, Bioflex® Performance Materials, and MEDIFIX Solutions™ wearable medical device fixation along with the company’s broad manufacturing capabilities.
Click to view Scapa's latest Annual Report and Accounts 2016
Trading Statement - October 2016
Scapa Group plc (AIM: SCPA), a global supplier of bonding solutions and manufacturer of adhesive based products for the Healthcare and Industrial markets, is today providing a period end update for the six months ended 30 September 2016. Click here »
Scapa Healthcare Expands Turn-Key Solutions with Regulatory & Compliance Services
Today, Scapa Healthcare, a strategic outsource partner of skin friendly turn-key solutions for the healthcare industry, announces the launch of its Regulatory Services offering. Providing full-service regulatory and compliance support will afford customers a more comprehensive partnership for the design, development and manufacturing of skin contact solutions, particularly Class II & III medical devices. Click here »
Preliminary Results 2016
Scapa Group plc (AIM: SCPA), a leading global manufacturer of bonding products and adhesive components for applications in the healthcare and industrial markets, today announces its Preliminary Results for the year ended 31 March 2016. Click here »